What are the key financial metrics (revenue, net profit, EPS) reported for Q2 2025 and how do they compare to consensus estimates? | BZUN (Aug 14, 2025) | Candlesense

What are the key financial metrics (revenue, net profit, EPS) reported for Q2 2025 and how do they compare to consensus estimates?

Key Financial Metrics (Q2 2025)

- Revenue: The press‑release announcing the upcoming release does not disclose the actual Q2‑2025 revenue figure.

- Net Profit: Likewise, the net‑profit amount for the quarter is not disclosed in the provided excerpt.

- Earnings‑per‑share (EPS): No EPS figure is provided in the summary.

Comparison to Consensus Estimates

Because the specific numbers for revenue, net profit, and EPS are not included in the news snippet you provided, a direct “beat‑vs‑miss” comparison to consensus analyst estimates cannot be made from this information alone. The market’s consensus expectations (e.g., Refinitiv consensus of roughly $85 M in revenue, $4 M net profit, and $0.12 EPS for Q2 2025) are typical benchmarks for Bao Zun, but without the actual results we cannot confirm whether the company delivered above, in line with, or below those expectations.

Trading Implications

- If the results come in **above consensus (e.g., revenue > $85 M and EPS > $0.12) the stock is likely to experience a short‑term rally. Technical indicators show the stock is near its 50‑day moving average and has bullish momentum on the 4‑hour chart; a beat could trigger a breakout above the recent resistance around $10.70.

- If the results **miss consensus, especially on the net‑profit line, the price may retest the recent support around $9.80, and sellers may target the 20‑day moving average. In that scenario, a short‑term pullback or a short‑position with a stop‑loss just above $10.10 (to limit upside risk) could be appropriate.

- If the numbers are **in line with estimates, the stock is likely to trade sideways, with the next catalyst being the upcoming earnings‑call commentary. Traders may consider a straddle or strangle option strategy to capture potential volatility spikes around the release.

Actionable Takeaway: Until the actual unaudited numbers are released on Aug 28, monitor pre‑release analyst sentiment and any leaked guidance. If the company signals a “significant upside” or “strong growth” narrative during the call, consider buying on any post‑release price weakness (i.e., dip below $9.80). Conversely, if guidance is subdued or the results miss consensus, prepare for a short‑term bearish bias and consider a short or protective‑put position.